The role of fetuin-A in cardiac functions and metabolism in peritoneal dialysis patients

Minerva Urologica e Nefrologica

Volumn 67, Issue 4, 2015, Pages 375-382

  Aydin, Z ^a   Ozturk, S ^a   Celik, C ^a   Gursu, M ^a   Karadag, S ^a   Yamak, M ^a   Basinoglu, F ^a   Gurdal, A ^b   Sumnu, A ^a   Cebeci, E ^a   Sakci, E ^a   Sar, F ^a   Kazancioglu R ^c  

^a HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c BEZMIALEM VAKIF UNIVERSITY   (Turkey)

Author keywords

Echocardiography; Peritoneal dialysis; Uremia; Vascular calciication.

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CALCIUM; CREATININE; FERRITIN; FETUIN A; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IRON; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHORUS; POTASSIUM; SERUM ALBUMIN; SODIUM; TRIACYLGLYCEROL; UREA; URIC ACID; AHSG PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD VESSEL CALCIFICATION; CHRONIC KIDNEY FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CREATININE CLEARANCE; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE METABOLISM; HUMAN; ISCHEMIC HEART DISEASE; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PERITONEAL DIALYSIS; SYSTOLIC BLOOD PRESSURE; ADOLESCENT; AGED; CARDIAC MUSCLE; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; GENETICS; HEART; HEART FUNCTION TEST; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA-2-HS-GLYCOPROTEIN; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEART; HEART FUNCTION TESTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PERITONEAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; YOUNG ADULT;

EID: 85009119434     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Collins AJ. Cardiovascular mortality in end-stage renal disease. Am J Med Sci 2003;325:163-7.
2. Tamura T, Bergman SM, Morgan SL. Homocysteine, B vitamins, and vascular-Access thrombosis in patients treated with hemodialysis. Am J Kidney Dis 1998;32:475-81.
3. Collett GD, Canield AE. Angiogenesis and pericytes in the initiation of ectopic calciication. Circ Res 2005;96:930-8.
4. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calciication in osteoporotic patients. Arterioscler Thromb Vasc Biol 1997;17:680-7.
5. Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-Alpha promotes in vitro calciication of vascular cells via the cAMP pathway. Circulation 2000;102:2636-42.
6. Hirata M, Katsumata K, Endo K, Fukushima N, Ohkawa H, Fukagawa M. In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calciication or deterioration of residual renal function than 1, 25(OH) 2 vitamin D 3. Nephrol Dial Transplant 2003;18:1770-6.
7. Watson KE, Parhami F, Shin V, Demer LL. Fibronectin and collagen I matrixes promote calciication of vascular cells in vitro, whereas collagen IV matrix is inhibitory. Arterioscler Thromb Vasc Biol 1998;18:1964-71.
8. Watson KE, Bostrom K, Ravindranath R, Lam T, Norton B, Demer LL. TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 1994;93:2106-13.
9. Yamagishi S, Fujimori H, Yonekura H, Tanaka N, Yamamoto H. Advanced glycation endproducts accelerate calciication in microvascular pericytes. Biochem Biophys Res Commun 1999;258:353-7.
10. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer LL, et al. Spontaneous calciication of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997;386:78-81.
11. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, et al. The serum protein alpha-2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calciication. J Clin Invest 2003;112:357-66.
12. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, et al. Osteoprotegerin-deicient mice develop early-onset osteoporosis and arterial calciication. Genes Dev 1998;12:1260-8.
13. Lebreton JP, Joisel F, Raoult JP, Lannuzel B, Rogez JP, Humbert G. Serum concentration of human alpha 2 HS glycoprotein during the inlammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest 1979;64:1118-29.
14. Ketteler M, Wanner C, Metzger T, Bongartz P, Westenfeld R, Gladziwa U, et al. Deiciencies of calcium-regulatory proteins in dialysis patients: A novel concept of cardiovascular calciication in uremia. Kidney Int Suppl 2003;84:84-7.
15. Ketteler M, Bongarz P, Westenfeld R, Wildberger JE, Mahnken AH, Böhm R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A crosssectional study. Lancet 2003;361:827-33.
16. Kalabay L, Cseh K, Jakab L, Pozsonyi T, Jakab L, Benedek S, et al. Diagnostic value of the determination of serum alpha2-HS-glycoprotein. Orv Hetil 1992;133:1553-4.
17. Honda H, Qureshi AR, Heimburger O, Barany P, Wang K, Pecoits-Filho R. Serum albumin, C-reactive protein, interleukin 6, and fetuin-A as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006;47:139-8.
18. Wang AY, Woo J, Lam CW, Wang M, Chan IH, Gao P, et al. Associations of serum fetuin-A with malnutrition, inlammation, atherosclerosis and valvular calciication syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 2005;20:1676-85.
19. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: The Framingham Heart Study. Am J Cardiol 1987;59:956-60.
20. Foley RN, Parfrey PS. Cardiovascular disease and mortality in ESRD. J Nephrol 1988;11:239-45.
21. Moe SM, Reslerova M, Ketteler M, Oneill K, Duan D, Koczman J, et al. Role of calciication inhibitors in the pathogenesis of vascular calciication in chronic kidney disease (CKD). Kidney Int 2005;67:2295-304.
22. Hermans MM, Brandenburg V, Ketteler M, Kooman JP, van der Sande FM, et al. Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis. Nephrol Dial Transplant 2006;21:1293-9.
23. Talib A, Nakagawa N, Saito E, Matsuki M, Kobayashi M, Akasaka K, et al. The balance of fetuin-A and osteoprotegerin is independently associated with diastolic dysfunction in hemodialysis patients. Hypertens Res 2012;35:426-33.
24. Oikawa O, Higuchi T, Yamazaki T, Yamamoto C, Fukuda N, Matsumoto K. Evaluation of serum fetuin-A relationships with biochemical parameters in patients on hemodialysis. Clin Exp Nephrol 2007;11:304-8.
25. Chen HY, Chiu YL, Hsu SP, Pai MF, Lai CF, Peng YS, et al. Association of serum fetuin-A with truncal obesity and dyslipidemia in non-diabetic hemodialysis patients. Eur J Endocrinol 2009;160:777-83.